List of Tables
Table 1. Global Drug Eluting Coronary Stent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Drug Eluting Coronary Stent Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Drug Eluting Coronary Stent Market Competitive Situation by Manufacturers in 2024
Table 4. Global Drug Eluting Coronary Stent Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Drug Eluting Coronary Stent Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Drug Eluting Coronary Stent Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Drug Eluting Coronary Stent Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Drug Eluting Coronary Stent Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Drug Eluting Coronary Stent, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Drug Eluting Coronary Stent, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Drug Eluting Coronary Stent, Product Type & Application
Table 12. Global Key Manufacturers of Drug Eluting Coronary Stent, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drug Eluting Coronary Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Coronary Stent as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drug Eluting Coronary Stent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Drug Eluting Coronary Stent Sales by Region (2020-2025) & (K Units)
Table 18. Global Drug Eluting Coronary Stent Sales Market Share by Region (2020-2025)
Table 19. Global Drug Eluting Coronary Stent Sales by Region (2026-2031) & (K Units)
Table 20. Global Drug Eluting Coronary Stent Sales Market Share by Region (2026-2031)
Table 21. Global Drug Eluting Coronary Stent Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Drug Eluting Coronary Stent Revenue Market Share by Region (2020-2025)
Table 23. Global Drug Eluting Coronary Stent Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Drug Eluting Coronary Stent Revenue Market Share by Region (2026-2031)
Table 25. North America Drug Eluting Coronary Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Drug Eluting Coronary Stent Sales by Country (2020-2025) & (K Units)
Table 27. North America Drug Eluting Coronary Stent Sales by Country (2026-2031) & (K Units)
Table 28. North America Drug Eluting Coronary Stent Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Drug Eluting Coronary Stent Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Drug Eluting Coronary Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Drug Eluting Coronary Stent Sales by Country (2020-2025) & (K Units)
Table 32. Europe Drug Eluting Coronary Stent Sales by Country (2026-2031) & (K Units)
Table 33. Europe Drug Eluting Coronary Stent Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Drug Eluting Coronary Stent Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Drug Eluting Coronary Stent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Drug Eluting Coronary Stent Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Drug Eluting Coronary Stent Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Drug Eluting Coronary Stent Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Drug Eluting Coronary Stent Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drug Eluting Coronary Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Drug Eluting Coronary Stent Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Drug Eluting Coronary Stent Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Drug Eluting Coronary Stent Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Drug Eluting Coronary Stent Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Drug Eluting Coronary Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Drug Eluting Coronary Stent Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Drug Eluting Coronary Stent Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Drug Eluting Coronary Stent Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Drug Eluting Coronary Stent Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Drug Eluting Coronary Stent Sales (K Units) by Type (2020-2025)
Table 51. Global Drug Eluting Coronary Stent Sales (K Units) by Type (2026-2031)
Table 52. Global Drug Eluting Coronary Stent Sales Market Share by Type (2020-2025)
Table 53. Global Drug Eluting Coronary Stent Sales Market Share by Type (2026-2031)
Table 54. Global Drug Eluting Coronary Stent Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Drug Eluting Coronary Stent Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Drug Eluting Coronary Stent Revenue Market Share by Type (2020-2025)
Table 57. Global Drug Eluting Coronary Stent Revenue Market Share by Type (2026-2031)
Table 58. Global Drug Eluting Coronary Stent Price (US$/Unit) by Type (2020-2025)
Table 59. Global Drug Eluting Coronary Stent Price (US$/Unit) by Type (2026-2031)
Table 60. Global Drug Eluting Coronary Stent Sales (K Units) by Application (2020-2025)
Table 61. Global Drug Eluting Coronary Stent Sales (K Units) by Application (2026-2031)
Table 62. Global Drug Eluting Coronary Stent Sales Market Share by Application (2020-2025)
Table 63. Global Drug Eluting Coronary Stent Sales Market Share by Application (2026-2031)
Table 64. Global Drug Eluting Coronary Stent Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Drug Eluting Coronary Stent Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Drug Eluting Coronary Stent Revenue Market Share by Application (2020-2025)
Table 67. Global Drug Eluting Coronary Stent Revenue Market Share by Application (2026-2031)
Table 68. Global Drug Eluting Coronary Stent Price (US$/Unit) by Application (2020-2025)
Table 69. Global Drug Eluting Coronary Stent Price (US$/Unit) by Application (2026-2031)
Table 70. Boston Scientific Company Information
Table 71. Boston Scientific Description and Business Overview
Table 72. Boston Scientific Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Boston Scientific Drug Eluting Coronary Stent Product
Table 74. Boston Scientific Recent Developments/Updates
Table 75. Medtronic Company Information
Table 76. Medtronic Description and Business Overview
Table 77. Medtronic Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Medtronic Drug Eluting Coronary Stent Product
Table 79. Medtronic Recent Developments/Updates
Table 80. Abbott Company Information
Table 81. Abbott Description and Business Overview
Table 82. Abbott Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Abbott Drug Eluting Coronary Stent Product
Table 84. Abbott Recent Developments/Updates
Table 85. Sahajanand Laser Technology Limited (SLTL Group) Company Information
Table 86. Sahajanand Laser Technology Limited (SLTL Group) Description and Business Overview
Table 87. Sahajanand Laser Technology Limited (SLTL Group) Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Sahajanand Laser Technology Limited (SLTL Group) Drug Eluting Coronary Stent Product
Table 89. Sahajanand Laser Technology Limited (SLTL Group) Recent Developments/Updates
Table 90. Meril Life Sciences Company Information
Table 91. Meril Life Sciences Description and Business Overview
Table 92. Meril Life Sciences Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Meril Life Sciences Drug Eluting Coronary Stent Product
Table 94. Meril Life Sciences Recent Developments/Updates
Table 95. Concept Medical Company Information
Table 96. Concept Medical Description and Business Overview
Table 97. Concept Medical Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Concept Medical Drug Eluting Coronary Stent Product
Table 99. Concept Medical Recent Developments/Updates
Table 100. BIOTRONIK Company Information
Table 101. BIOTRONIK Description and Business Overview
Table 102. BIOTRONIK Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. BIOTRONIK Drug Eluting Coronary Stent Product
Table 104. BIOTRONIK Recent Developments/Updates
Table 105. Relisys Company Information
Table 106. Relisys Description and Business Overview
Table 107. Relisys Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Relisys Drug Eluting Coronary Stent Product
Table 109. Relisys Recent Developments/Updates
Table 110. Lepu Medical Technology(Beijing) Company Information
Table 111. Lepu Medical Technology(Beijing) Description and Business Overview
Table 112. Lepu Medical Technology(Beijing) Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Lepu Medical Technology(Beijing) Drug Eluting Coronary Stent Product
Table 114. Lepu Medical Technology(Beijing) Recent Developments/Updates
Table 115. Micell Technologies Company Information
Table 116. Micell Technologies Description and Business Overview
Table 117. Micell Technologies Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Micell Technologies Drug Eluting Coronary Stent Product
Table 119. Micell Technologies Recent Developments/Updates
Table 120. Terumo Corporation Company Information
Table 121. Terumo Corporation Description and Business Overview
Table 122. Terumo Corporation Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Terumo Corporation Drug Eluting Coronary Stent Product
Table 124. Terumo Corporation Recent Developments/Updates
Table 125. Biosensors International Company Information
Table 126. Biosensors International Description and Business Overview
Table 127. Biosensors International Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Biosensors International Drug Eluting Coronary Stent Product
Table 129. Biosensors International Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Drug Eluting Coronary Stent Distributors List
Table 133. Drug Eluting Coronary Stent Customers List
Table 134. Drug Eluting Coronary Stent Market Trends
Table 135. Drug Eluting Coronary Stent Market Drivers
Table 136. Drug Eluting Coronary Stent Market Challenges
Table 137. Drug Eluting Coronary Stent Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Drug Eluting Coronary Stent
Figure 2. Global Drug Eluting Coronary Stent Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug Eluting Coronary Stent Market Share by Type: 2024 & 2031
Figure 4. Sirolimus Product Picture
Figure 5. Everolimus Product Picture
Figure 6. Others Product Picture
Figure 7. Global Drug Eluting Coronary Stent Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Drug Eluting Coronary Stent Market Share by Application: 2024 & 2031
Figure 9. Angina Pectoris
Figure 10. Myocardial Infarction
Figure 11. Global Drug Eluting Coronary Stent Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Drug Eluting Coronary Stent Market Size (2020-2031) & (US$ Million)
Figure 13. Global Drug Eluting Coronary Stent Sales (2020-2031) & (K Units)
Figure 14. Global Drug Eluting Coronary Stent Average Price (US$/Unit) & (2020-2031)
Figure 15. Drug Eluting Coronary Stent Report Years Considered
Figure 16. Drug Eluting Coronary Stent Sales Share by Manufacturers in 2024
Figure 17. Global Drug Eluting Coronary Stent Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Drug Eluting Coronary Stent Players: Market Share by Revenue in Drug Eluting Coronary Stent in 2024
Figure 19. Drug Eluting Coronary Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Drug Eluting Coronary Stent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Drug Eluting Coronary Stent Sales Market Share by Country (2020-2031)
Figure 22. North America Drug Eluting Coronary Stent Revenue Market Share by Country (2020-2031)
Figure 23. United States Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Drug Eluting Coronary Stent Sales Market Share by Country (2020-2031)
Figure 26. Europe Drug Eluting Coronary Stent Revenue Market Share by Country (2020-2031)
Figure 27. Germany Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Drug Eluting Coronary Stent Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Drug Eluting Coronary Stent Revenue Market Share by Region (2020-2031)
Figure 34. China Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Drug Eluting Coronary Stent Sales Market Share by Country (2020-2031)
Figure 42. Latin America Drug Eluting Coronary Stent Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Drug Eluting Coronary Stent Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Drug Eluting Coronary Stent Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Drug Eluting Coronary Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Drug Eluting Coronary Stent by Type (2020-2031)
Figure 52. Global Revenue Market Share of Drug Eluting Coronary Stent by Type (2020-2031)
Figure 53. Global Drug Eluting Coronary Stent Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Drug Eluting Coronary Stent by Application (2020-2031)
Figure 55. Global Revenue Market Share of Drug Eluting Coronary Stent by Application (2020-2031)
Figure 56. Global Drug Eluting Coronary Stent Price (US$/Unit) by Application (2020-2031)
Figure 57. Drug Eluting Coronary Stent Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
